COMMITTEES & WORKING GROUPS
Our work is supported by the engagement of our members and carried out through our Committees or Working Groups (WGs). These committees, utilizing collective knowledge and experience, promote dialogue and cooperation in order to formulate positions and strategies for addressing and resolving critical issues in the industry.
Eleven (11) committees operate in the Association:
- Reimbursement & HTA
- Pricing
- Communication & Patient Think Tank
- Public Affairs
- Scientific Affairs
- Pharmaceutical Expenditure & Hospitals
- Legal
- Ethics & Compliance
- Financial Affairs & Development
- Documentation
- Human Resources
The Committees are composed of executives from our member companies, but also experts and other stakeholders with knowledge and experience in the areas of interest.
Indicative areas of action are the following:
- Ensuring the value and accessibility of medicines.
- Shaping the current and future environment between the pharmaceutical industry and the NHS.
- Monitoring financial and compensation issues related to ensuring the sustainability of the NHS and pharmaceutical companies, with a view to improving the commercial, business and investment environment.
- Strengthening the trust and reputation of the industry through targeted actions on issues that affect the perceptions of society and health professionals in the country.